Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients

BACKGROUND: Clinical data identified an association between the use of HMG-CoA reductase inhibitors (statins) and incident diabetes in patients with underlying diabetes risk factors such as obesity, hypertension and dyslipidemia. The molecular mechanisms however are unknown. METHODS: An observationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Margerie, Daniel, Lefebvre, Philippe, Raverdy, Violeta, Schwahn, Uwe, Ruetten, Hartmut, Larsen, Philip, Duhamel, Alain, Labreuche, Julien, Thuillier, Dorothée, Derudas, Bruno, Gheeraert, Céline, Dehondt, Hélène, Dhalluin, Quentin, Alexandre, Jérémy, Caiazzo, Robert, Nesslany, Pamela, Verkindt, Helene, Pattou, François, Staels, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545676/
https://www.ncbi.nlm.nih.gov/pubmed/31159817
http://dx.doi.org/10.1186/s12920-019-0536-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545676/
https://www.ncbi.nlm.nih.gov/pubmed/31159817
http://dx.doi.org/10.1186/s12920-019-0536-1

Ejemplares similares